Tres alchemix AI創薬プラットフォーム研究開発
4 employees on LinkedIn · 1 known investors
Tres Alchemix develops AI platforms that combine quantum-level chemical calculations with multi-omics models trained on curated biochemical and pharmacological data to predict how chemicals behave in the human body, including drug properties, chemical-protein interactions, and pharmacokinetics/pharmacodynamics. The company applies these technologies to AI-driven drug development and biological research questions.
Investors · 1
Frequently asked questions
- What does Tres alchemix AI創薬プラットフォーム研究開発 do?
- Tres Alchemix develops AI platforms that combine quantum-level chemical calculations with multi-omics models trained on curated biochemical and pharmacological data to predict how chemicals behave in the human body, including drug properties, chemical-protein interactions, and pharmacokinetics/pharmacodynamics. The company applies these technologies to AI-driven drug development and biological research questions.
- Who are Tres alchemix AI創薬プラットフォーム研究開発's investors?
- Tres alchemix AI創薬プラットフォーム研究開発's investors include Dnx Ventures.